Reducing Disparities in Medication Adherence in SLE

Duke University

Status: Completed

Conditions: Systemic Lupus Erythematosus

Treatments: Behavioral: Behavioral Intervention

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT03738826

Pro00100861

5U54MD012530-02 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This is a pilot study to assess the feasibility of using Surescripts refill data during the clinical encounter to improve medication adherence in patients with systemic lupus erythematosus

Enrollment: 135 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

• All followup patients seen at the Duke Lupus clinic

Exclusion Criteria

• Patients not seen at the Duke Lupus Clinic
• New patients seen for the first time at the Duke Lupus Clinic
• Patients who are not prescribed any lupus medications

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

135 participants in 1 patient group

Intervention arm

Experimental group

Description:

Lupus clinic providers will use Surescripts refill information to assess adherence level and address adherence barriers. We will assess the feasibility and acceptability of the intervention.

Treatment:

Behavioral: Behavioral Intervention